Investing First patient dosed in Phase IIb imaging for Brain Mets by April 28, 2025 written by April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 comment 0 FacebookTwitterPinterestEmail previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? Related Articles Forte Minerals Announces Private Placement of up to... May 24, 2025 Precious Metals & Critical Minerals Hybrid Investor Conference:... May 24, 2025 Crypto Market Recap: Bitcoin Breaks US$111,000, Trump Courts... May 24, 2025 Josef Schachter: Oil to US$80 by Q4? Plus... May 24, 2025 Editor’s Picks: ECB Issues Gold Warning, Uranium Stocks... May 24, 2025 Harvest Gold Soil Sampling Program Reveals Several New... May 23, 2025 Silver47 Announces Graduation to Tier 1 Status on... May 23, 2025 Thick High-Grade Graphite Drilling Results In New Zone May 23, 2025 Rio Tinto Partners with Codelco to Develop Lithium... May 23, 2025 Group Eleven Announces Uplisting to OTCQB Market May 23, 2025